Merck asks FDA to authorize its promising anti-COVID-19 pill

3 years ago 303

items.[0].image.alt

AP

This undated representation provided by Merck & Co. shows their caller antiviral medication. The drugmaker has said its experimental pill for radical sick with COVID-19 reduced hospitalizations and deaths. (Merck & Co. via AP)

Merck antiviral

Posted at 5:49 AM, Oct 11, 2021

and past updated 2021-10-11 06:49:39-04

WASHINGTON— Drugmaker Merck has asked U.S. regulators to authorize its promising antiviral pill against COVID-19, mounting the signifier for a determination wrong weeks.

If cleared by the Food and Drug Administration, it would beryllium the archetypal pill shown to dainty COVID-19, adding a new, easy-to-use limb to the world's arsenal against the pandemic.

The FDA volition scrutinize institution information connected the drug’s information and effectiveness earlier rendering a decision.

All COVID-19 drugs present authorized by the FDA necessitate an IV oregon injection.

This communicative is breaking and volition beryllium updated.

Copyright 2021 Scripps Media, Inc. All rights reserved. This worldly whitethorn not beryllium published, broadcast, rewritten, oregon redistributed.

Read Entire Article